Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

Expert Dr. Irl Hirsch’s eight tips for managing diabetes on a budget.
What are the most solvable problems in diabetes?
Twitter Summary: Glucose info right on your wrist? Microsoft/Apple rumored smart watches might make that a reality We first wrote about Google’s venture into the...
Twitter summary: Contrave launched in the US w/ weight support program + savings/loyalty programs offer new option for patients Two healthcare companies, Orexigen and...
On June 27, the FDA approved MannKind’s Afrezza for type 1 and type 2 diabetes, a new rapid-acting inhaled insulin. We’ve been following this story for years in diaTribe...
Twitter summary: BI/Lilly’s #insulin glargine receives EU approval – “Abrasia” set to launch in mid-2015 as 1 st ever “biosimilar” insulin in Europe On September 10, Eli...
How are the bacteria in our gut related to type 2 diabetes and obesity? The fascinating research.
An illuminating FDA workshop on bolus calculators and device interoperability identifies key unmet needs in diabetes technology - Adam Brown makes a patient presentation!
On June 19, Novo Nordisk announced the launch of its FlexTouch pen for the long-acting basal insulin Levemir (insulin detemir). FlexTouch, which has been approved in...
On September 24, JAMA published a paper on long-term trends in the number of people with diabetes in the United States from 1980 to 2012. The results showed a leveling-...
What can diabetes advocates learn from the HIV/AIDS movement? Part five of our exclusive interview with David Panzirer and Dana Ball.
The curious milestone of a diabetes anniversary.
Twitter summary: FDA grants “tentative approval” to Lilly/BI’s Basaglar – new insulin option will be an alternative to Lantus in future On August 18, Eli Lilly and...
Twitter summary: FDA approves Xigduo XR – first once-daily SGLT-2 inhibitor/metformin fixed dose combo in the US AstraZeneca recently announced that the FDA approved...
Can artificial sweeteners contribute to weight gain and worse diabetes control? A remarkable new study on the role of gut bacteria...
Update (1/12/15): Medtronic Diabetes gave an update on their upcoming diabetes device pipeline at the J.P. Morgan Healthcare Conference. The MiniMed 640G is expected to...
Twitter summary: New Bydureon pen launched in US – more user-friendly “twist, tap, twist” procedure simplifies the injection process AstraZeneca recently launched its...
This year at ADA, the science was exciting as always, but what really made us happy was the deep focus on patient perspectives.
On July 9, NeuroMetrix announced that the FDA had granted clearance for over-the-counter use of the Sensus pain management system for diabetic peripheral neuropathy (DPN...
Twitter Summary: @LillyPad receives EU approval for Humalog 200 units/ml Kwikpen – 600 units of insulin in a 3 ml pen, hopeful US resubmission late 2014 Eli Lilly...

Pages